NCBI PubMed Central
open access
A Pilot Serum Metabolomics Reveals Mitochondrial Dysfunction and Identifies Methylguanidine as a Potential Diagnostic Biomarker for ATAAD with Mesenteric Malperfusion Syndrome.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Exploring Biomarkers in Hereditary Transthyretin Amyloidosis#885121
- The MEK inhibitor trametinib incurs mitochondrial injury and induces innate immune responses in the mouse heart#485056
- New Biomarkers and Plasma Prothrombotic Potential in Cardiac Transthyretin Amyloidosis#802547
- Metabolomics of Cancers of the Upper Aerodigestive Tract#908258
- Loss of the Mechanistic Target of Rapamycin Complex 1 Causes a Lethal Alpha-1 Antitrypsin Deficiency–Associated Liver Disease / Lisa Bewersdorf, Sophie Haber, Ines Volkert, Katharina Remih, Annika Gross, Christian Preisinger, Linda Kroll, Thorsten Cramer, Nadine Gaisa, Sophie Leypold, Ulrike Rolle-Kampczyk, Nicola Brunetti-Pierri, Martin von Bergen, Florian Rosenberger, Caroline Weiss, Nurdan Güldiken, Pavel Strnad#629043
Record · ID 140616
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive